Therapy Areas
29 September 2023 - Medical device company SeaStar Medical Holding Corporation (Nasdaq:ICU) announced on Friday that it has secured Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its cell-directed Selective Cytophe...
29 September 2023 - ImmunoGenesis, a US-based clinical-stage biotechnology company developing science-driven immunotherapies, announced on Thursday that it has dosed its first subject in the company's Phase 1a/1b clinical trial of its lead candi...
29 September 2023 - Peptone, a UK-based translational biophysics company, announced on Thursday that it has named Patrik Foerch, PhD as its new chief scientific officer, David Lowe, PhD as its new senior vice president of Protein Therapeutics; Benjam...
28 September 2023 - Evommune, Inc., a California-based biotechnology company, announced on Wednesday that it has signed a strategic collaboration with Maruho Co., Ltd., a Japan-based pharmaceutical company that researches, develops, produces, and dis...
28 September 2023 - IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a California-based precision medicine oncology company, announced on Wednesday that it has received fast track designation from the US Food and Drug Administration (FDA) for its development...
27 September 2023 - YS Biopharma Co., Ltd. (NASDAQ: YS), a China-based global biopharmaceutical company, announced on Tuesday that it has enrolled its first subject in its Phase three clinical trial of the Company's PIKA Rabies Vaccine.The trial...